This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Hapvida-Plamed deal cleared in Brazil conditioned on divestitures in healthcare plan market in Sergipe state

( February 24, 2021, 18:50 GMT | Official Statement) -- MLex Summary: Health insurer Hapvida’s planned acquisition of Plamed’s customer portfolio was approved conditioned on the sale of Plamed's client portfolios of individual or family medical-hospital healthcare plans and of collective medical-hospital healthcare plans in Aracajú city in Sergipe state, according to a statement. The Administrative Council for Economic Defense, or CADE, also imposed behavioral remedies on the parties, including maintaining Hapvida's prices for individual or family medical-hospital healthcare plans in Aracajú for two years.CADE press release follows in Portuguese....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login